---
figid: PMC3116244__2045-3701-1-5-1
figtitle: Signaling Pathways Altered in Hepatic Cancer Stem Cells
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC3116244
filename: 2045-3701-1-5-1.jpg
figlink: /pmc/articles/PMC3116244/figure/F1/
number: F1
caption: Signaling Pathways Altered in Hepatic Cancer Stem Cells. Wnt/β-catenin, PI3K/PTEN/AKT,
  TGF-β/IGF-2R and IL-6/IL-6R/gp130 signaling pathways have been shown to be activated
  in HCC. Activation of the Wnt pathway results in β-catenin accumulation in the cytosol
  and translocation into the nucleus, where β-catenin forms two major protein-DNA
  complexes. 1) β-catenin/TCF/LEF is a classic complex of Wnt/β-catenin pathway that
  mediates Wnt target genes expression, e.g. EpCAM and miR-181; 2) EpICD/FHL2/β-catenin/LEF1-DNA
  complex represents a cross-talk of Wnt/β-catenin with EpCAM signaling pathway [].
  Cleavage of EpCAM by TACE and PS-2 releases EpICD into cytosol which in turn translocates
  into the nuclues with β-catenin and FHL2, where EpICD/FHL2/β-catenin forms protein-DNA
  complex with LEF1and regulates EpCAM target genes expression, e.g. cyclin D1, c-Myc
  andd miR-181. AKT is activated by two phosphorylation sitess Thr308 and Ser473.
  Phosphorylation of Thr308 is promoted by PI3K and suppressed by PTEN. Activated
  AKT induces cell survival through the suppressive phosphorylation of BAD and Caspase
  9, two apoptosis mediators in unphophorylated status. AKT also acts as a cell cycle
  progression regulator through activating the mTOR pathway []. Two oncogenic pathways
  PI3K/PTEN/AKT and Wnt/β-catenin may be interconnected to promote stemness and carcinogenesis.
  Loss of IGF-2R impacts cell proliferation by accumulating IGF-2 mitogen and activation
  of TGF-β signaling.
papertitle: 'Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic
  cholangiocarcinoma: one step closer to personalized medicine?.'
reftext: Mia Kumar, et al. Cell Biosci. 2011;1:5-5.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9472349
figid_alias: PMC3116244__F1
figtype: Figure
redirect_from: /figures/PMC3116244__F1
ndex: abfb24f5-def8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3116244__2045-3701-1-5-1.html
  '@type': Dataset
  description: Signaling Pathways Altered in Hepatic Cancer Stem Cells. Wnt/β-catenin,
    PI3K/PTEN/AKT, TGF-β/IGF-2R and IL-6/IL-6R/gp130 signaling pathways have been
    shown to be activated in HCC. Activation of the Wnt pathway results in β-catenin
    accumulation in the cytosol and translocation into the nucleus, where β-catenin
    forms two major protein-DNA complexes. 1) β-catenin/TCF/LEF is a classic complex
    of Wnt/β-catenin pathway that mediates Wnt target genes expression, e.g. EpCAM
    and miR-181; 2) EpICD/FHL2/β-catenin/LEF1-DNA complex represents a cross-talk
    of Wnt/β-catenin with EpCAM signaling pathway []. Cleavage of EpCAM by TACE and
    PS-2 releases EpICD into cytosol which in turn translocates into the nuclues with
    β-catenin and FHL2, where EpICD/FHL2/β-catenin forms protein-DNA complex with
    LEF1and regulates EpCAM target genes expression, e.g. cyclin D1, c-Myc andd miR-181.
    AKT is activated by two phosphorylation sitess Thr308 and Ser473. Phosphorylation
    of Thr308 is promoted by PI3K and suppressed by PTEN. Activated AKT induces cell
    survival through the suppressive phosphorylation of BAD and Caspase 9, two apoptosis
    mediators in unphophorylated status. AKT also acts as a cell cycle progression
    regulator through activating the mTOR pathway []. Two oncogenic pathways PI3K/PTEN/AKT
    and Wnt/β-catenin may be interconnected to promote stemness and carcinogenesis.
    Loss of IGF-2R impacts cell proliferation by accumulating IGF-2 mitogen and activation
    of TGF-β signaling.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - WIF1
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ADAM17
  - PSEN2
  - TFF1
  - TAS2R64P
  - ADAR
  - DVL1P1
  - GATA5
  - CDX2
  - GSK3B
  - FHL2
  - APC
  - PROC
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - LEF1
  - CCND1
  - MYC
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - TP53
  - TP63
  - TP73
  - EPCAM
  - BAD
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - FOXO3
  - PTEN
  - HCC
  - HYCC1
  - TERT
  - CEBPB
  - STAT3
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - IGF2
  - IGF2R
  - TGFB1
  - TGFB2
  - TGFB3
  - EGR1
  - EGR2
  - EGR3
  - EGR4
  - IL6
  - IL6ST
  - NM
  - LRPPRC
  - IL6R
  - Cancer
---
